全文获取类型
收费全文 | 1157篇 |
免费 | 74篇 |
国内免费 | 77篇 |
专业分类
儿科学 | 33篇 |
妇产科学 | 17篇 |
基础医学 | 99篇 |
口腔科学 | 23篇 |
临床医学 | 159篇 |
内科学 | 256篇 |
皮肤病学 | 45篇 |
神经病学 | 33篇 |
特种医学 | 100篇 |
外科学 | 130篇 |
综合类 | 93篇 |
预防医学 | 62篇 |
眼科学 | 1篇 |
药学 | 222篇 |
中国医学 | 1篇 |
肿瘤学 | 34篇 |
出版年
2021年 | 7篇 |
2020年 | 6篇 |
2019年 | 11篇 |
2018年 | 15篇 |
2017年 | 12篇 |
2016年 | 12篇 |
2015年 | 12篇 |
2014年 | 15篇 |
2013年 | 27篇 |
2012年 | 33篇 |
2011年 | 38篇 |
2010年 | 35篇 |
2009年 | 39篇 |
2008年 | 42篇 |
2007年 | 108篇 |
2006年 | 60篇 |
2005年 | 52篇 |
2004年 | 63篇 |
2003年 | 44篇 |
2002年 | 35篇 |
2001年 | 40篇 |
2000年 | 44篇 |
1999年 | 44篇 |
1998年 | 38篇 |
1997年 | 30篇 |
1996年 | 33篇 |
1995年 | 27篇 |
1994年 | 16篇 |
1993年 | 24篇 |
1992年 | 23篇 |
1991年 | 21篇 |
1990年 | 16篇 |
1989年 | 33篇 |
1988年 | 14篇 |
1987年 | 18篇 |
1986年 | 21篇 |
1985年 | 21篇 |
1984年 | 10篇 |
1983年 | 10篇 |
1982年 | 11篇 |
1981年 | 15篇 |
1980年 | 11篇 |
1979年 | 7篇 |
1978年 | 13篇 |
1977年 | 10篇 |
1976年 | 8篇 |
1975年 | 9篇 |
1971年 | 8篇 |
1968年 | 10篇 |
1966年 | 5篇 |
排序方式: 共有1308条查询结果,搜索用时 15 毫秒
81.
Baillie J 《Endoscopy》2004,36(9):821-824
82.
83.
Johnson JL Kalaw C Lovato CY Baillie L Chambers NA 《Qualitative health research》2004,14(9):1276-1291
Although adolescents are often curious about cigarettes and anxious to "try" smoking, they are unsure about what engaging in the act of smoking will mean. Most adolescents who experiment with smoking do not set out to become addicted to tobacco. Using a grounded theory approach, the authors examined the process youth undergo to regain control over their smoking. Accounts of early smoking experiences suggest that youth undergo a process to control tobacco use that includes (a) determining if smoking is a problem, (b) "crossing the line" of acceptable tobacco use, and (c) implementing strategies to regain control of smoking. The findings of this study lay the basis for the development of harm reduction approaches that facilitate youth's propensity to control their tobacco use. 相似文献
84.
85.
The cell-invasive adenylate cyclase toxin (CyaA) of Bordetella pertussis was shown to be highly antigenic in mice, stimulating serum anti-CyaA IgG antibody responses which were able to neutralise the cytotoxic effect of CyaA on J774.2 macrophage-like cells. The effect of co-administration to mice of the fully functional CyaA toxin or a toxin lacking adenylate cyclase enzymic activity (CyaA*) with other antigens from B. pertussis, namely pertussis toxin (PT) or pertussis toxoid (PTd), filamentous haemagglutinin (FHA) and pertactin (PRN), was investigated. CyaA* enhanced the serum IgG antibody responses to each of these antigens whereas, with CyaA, only anti-PRN antibody titres showed a modest increase. Peritoneal macrophages and spleen cells, collected at 2 weeks post-immunisation, were cultured and tested for nitric oxide (NO) and IFNgamma production, respectively, after stimulation in vitro with heat-killed B. pertussis cells or CyaA proteins. NO and IFNgamma production were higher in cells collected from mice immunised with CyaA or CyaA* in combination with a PT, FHA and PRN antigen mixture than from those taken from mice injected with antigen mixture alone, again with CyaA* acting as a better adjuvant than CyaA. The apparent enhancement of immune responses to the antigen mixture by CyaA* in particular was not paralleled by increased protection of mice against aerosol challenge with B. pertussis, but a statistically significant increase in protection was seen after intranasal challenge with B. parapertussis. 相似文献
86.
Baillie AJ 《Journal of clinical epidemiology》2004,57(6):647-8; author reply 649-50
87.
Singh R Silva Elipe MV Pearson PG Arison BH Wong BK White R Yu X Burgey CS Lin JH Baillie TA 《Chemical research in toxicology》2003,16(2):198-207
Compound I, (2-[3-[(2,2-difluoro-2(2-pyridyl)ethyl)amino]-6-methyl-2-oxohydropyrazinyl]-N-[(3-fluoro(2-pyridyl))methyl]acetamide, is a potent competitive inhibitor of thrombin that reacts stoichiometrically with the protease. Compounds of this class possess therapeutic potential as anticoagulation agents. During the metabolic characterization of compound I, evidence was obtained for extensive metabolic activation of the pyrazinone ring system. Following administration of (14)C-labeled I to rats, significant levels of irreversibly bound radioactivity to proteins were detected in rat plasma and liver. LC/MS/MS analysis of metabolites formed in rat and human liver microsomes fortified with glutathione (GSH) revealed the presence of two structurally distinct GSH adducts. It is proposed that the first of these GSH conjugates derives from a two electron oxidation of the 6-methyl-2-oxo-3-aminopyrazinone moiety to afford an electrophilic imine-methide intermediate, while the second is formed by addition of GSH to an epoxide formed by P-450-mediated oxidation of the double bond at the 5-6 position of the pyrazinone ring. The addition of GSH to the proposed epoxide facilitates opening of the pyrazinone ring and a rearrangement to afford a stable, rearranged imidazole-containing metabolite. Elucidation of the metabolic activation pathways of I provides structural guidance for the design of thrombin inhibitors with decreased potential for the generation of chemically reactive intermediates. 相似文献
88.
Multicenter randomized trial of the spiral Z-stent compared with the Wallstent for malignant biliary obstruction 总被引:3,自引:0,他引:3
Shah RJ Howell DA Desilets DJ Sheth SG Parsons WG Okolo P Lehman GA Sherman S Baillie J Branch MS Pleskow D Chuttani R Bosco JJ 《Gastrointestinal endoscopy》2003,57(7):830-836
BACKGROUND: The industry standard since 1990 for self-expanding biliary metallic stents has been the Wallstent. In 1998 the Spiral Z-stent was released. This randomized trial compared the Z-stent with the Wallstent in the treatment of malignant biliary obstruction. METHODS: Patients with unresectable malignant biliary obstruction distal to the bile duct bifurcation were randomized to receive a 10-mm diameter Wallstent or a 10-mm diameter Z-stent. RESULTS: A total of 145 patients were randomized; 13 were excluded. Sixty-four patients who received a Z-stent and 68 who had a Wallstent are included in the analysis. Tumors responsible for bile duct obstruction were pancreatic cancer (108), cholangiocarcinoma (15), metastatic cancer (6), and papillary cancer (3). Metallic stents were successfully placed in all patients. Seven technical problems were encountered during placement of the Z-stent and 5 with the Wallstent. There were 21 occlusions requiring reintervention (8 Z-stent, 13 Wallstent; p = 0.30). Median time to reintervention was the following: Z-stent, 162 days; Wallstent, 150 days (p = 0.22). A total of 104 patients died of progressive disease or other cause; 7 patients remain alive with patent stents. The overall calculated median patency rates were: Z-stent, 152 days; Wallstent, 154 days (p = 0.90). CONCLUSIONS: The Spiral Z-stent is comparable with the Wallstent in terms of placement, occlusion rates, and overall patency. Occasional early occlusion of both stents suggests tumor characteristics instead of the size of the mesh openings in the stents as important factors. 相似文献
89.
90.